Has Matthew Sardelli, MD received payments from drug or device companies?

Yes. Drug and device makers reported $25,598 in general payments to Matthew Sardelli, MD across 115 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Matthew Sardelli, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Matthew Sardelli, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Matthew Sardelli, MD

Orthopaedic Surgery · Clarkston, MINPI 1992992705

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $17,515 of the $25,598 with a category attached, or 68.4%. Vericel Corporation accounts for 63.4% of it on its own, with 23 other manufacturers making up the rest. Reporting peaked in 2024 at $14,861 and has fallen 66.8% since, to $4,928 in 2025.

$25,598in general payments, 2019–2025

Across 115 payments — averaging $222.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Vericel Corporation$16K
Arthrex$5K
Pinnacle, Inc$1K
Stryker$675
Medwest Associates$436
Zimmer Biomet$423
plus $1K from 18 others

$39,298in ownership & investment interests, 2019–2025

Across 5 payments — averaging $7859.68 each. An ownership or investment interest held by the physician or an immediate family member.

Catalyst Orthoscience$39K

What the payments were for

Speaking & faculty fees$17,51568%
Travel & lodging$3,47914%
Food & beverage$4,47417%
Other$1291%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Vericel Corporation	15	$16,238
Arthrex	34	$4,893
Pinnacle, Inc	11	$1,444
Stryker	10	$675
Medwest Associates	4	$436
Zimmer Biomet	7	$423
Johnson & Johnson(2 entities)	7	$320
DJO, LLC	2	$179
Miach Orthopaedics, Inc.	1	$143
Smith+Nephew	5	$143
Microport Orthopedics Inc	2	$131
Welch Allyn	1	$129
Acumed LLC	1	$64
Bioventus LLC	2	$61
Globus Medical	1	$51
Heron Therapeutics, Inc.	2	$41
Vertex	2	$41
Embody, Inc.	1	$35
Ossur Americas, Inc.	1	$32
Amgen	2	$30
Convatec Inc.	1	$28
Biotissue Holdings Inc.	1	$24
Pacira Pharmaceuticals Incorporated	1	$22
Linvatec Corporation	1	$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

MACI$16,146
Juggerknotless Soft Anchor$399
BLUEPRINT PATIENT SPECIFIC INSTRUMENTATION$144
NONE$129
VARIAX$120
BIOLOGICS CONSUMABLES AUTOLOGOUS BLOOD PRODUCTS BONE MARROW$119
T2$114
BIOLOGICS CONSUMABLES ACCESSORIES BONE MARROW$110
MPO Medial Pivot Knee$107
BME NITINOL CONTINUOUS COMPRESSION IMPLANTS$106
IM NAILS$106
MAKO$101

How this compares

$25,598 in reported general payments places this provider in the 85th percentile of 829 orthopaedic surgery providers in Michigan.

See all orthopaedic surgery providers in Michigan →

Medicare billing

Part B allowed, 2024

$107,569

Medicare patients

167

Services billed

1,223

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	184	$1,087
Prochlorperazine Maleate	117	$757
Cephalexin	79	$448
Methylprednisolone	54	$299
Meloxicam	32	$231
Cyclobenzaprine Hcl	24	$148
Oxycodone Hcl	18	$134
Ibuprofen	13	$87
Naproxen	12	$79
Tramadol Hcl	49	$66
Acetaminophen-CodeineAcetaminophen With Codeine	13	$56
Gabapentin	15	$50
Amoxicillin	11	$10

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Clarkston

Asheesh BediAnn Arbor$9.4M
Jerome WiaterBeverly Hills$3.9M
Mark PintoChelsea$3.2M
Kyle AndersonBingham Farms$3.1M
Stephen BartolDetroit$2.6M
Jad KhalilSouthfield$1.9M
Jeffrey FischgrundSouthfield$1.8M
John BlahaAnn Arbor$1.5M
David MarkelSouthfield$1.5M
Christopher ChuinardTraverse City$1.4M

See the full list for Michigan →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →